Definitive Contract 75D30121C12574

Award Date 9/24/21
Potential Completion Date 9/26/25
Potential Value $3.2M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15260, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $749,996.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Pittsburgh, a state-related research university in Pennsylvania. The contract is for research under Broad Agency Announcement (BAA) Topic 21.6, which focuses on the impact of the COVID-19 pandemic on viral and bacterial pathogens causing acute otitis media in young children. The contract has a period of performance through September 18, 2025 and does not utilize a...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to the University of Pittsburgh, a major research university in Pennsylvania. The $148,349 firm fixed-price purchase order is for professional services and does not have a set-aside designation. The award is associated with the University of Pittsburgh's $146.3 million Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID) to provide preclinical models...
The University of Pittsburgh - Of The Commonwealth System Of Higher Education (the University) was awarded a firm fixed price, definitive contract by the Centers for Disease Control and Prevention (CDC) to develop innovative methods and strategies to evaluate the effect of vaccines in preventing outpatient, laboratory-confirmed illness. The contract has a potential value of $1,300,000 and a completion date of September 30, 2022. No set aside designation was applied. As the prime contractor,...
This federal contract award, valued at $9,014,126.00, was issued by a U.S. government agency to the University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh. The contract is for biomedical research and does not have a set-aside designation. The University of Pittsburgh is a state-related research university that frequently partners with industry, other academic institutions, and federally funded research centers to conduct research...
This is a definitive federal contract awarded by the Defense Health Agency (DHA), a defense agency, to the University of Pittsburgh (Pitt), a state-related research university in Pennsylvania. The $16,082,136.50 contract is for a variety of research and technical services, with a period of performance ending on September 22, 2020. This contract does not have a set-aside designation, as Pitt competes for such awards as a large public research institution. Pitt frequently partners with other...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Pittsburgh, a major research university in Pennsylvania. The $133,687 definitive contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. The University of Pittsburgh frequently partners with government agencies on federally funded research projects. In this case, the...
This federal contract award, valued at $15,770.76, was made by the Department of Veterans Affairs to the University of Pittsburgh - Of The Commonwealth System of Higher Education. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of March 31, 2026. The University of Pittsburgh is a major public research university with extensive capabilities in scientific and medical research across various domains. This contract does not have a...
The University of Pittsburgh has been awarded a $50,000.00 firm fixed-price purchase order contract by the Office of Naval Research (ONR), a component of the Department of Defense. The contract is for a yearly membership and does not have a set-aside designation. As a large public research university, the University of Pittsburgh frequently partners with government agencies to conduct scientific research and provide technical services. This contract is likely part of the university's broader...
This is a $1,032,667.51 firm fixed-price research services contract awarded by the Department of Veterans Affairs to the University of Pittsburgh. The contract has no set-aside designation, indicating it was competed openly. The University of Pittsburgh is a large public research institution that frequently partners with government agencies on federally funded research projects across disciplines like biomedical sciences, engineering, and public health. This contract supports the National...
This $380,715 firm fixed-price contract was awarded by the National Institute of Environmental Health Sciences (NIEHS) to the University of Pittsburgh, a major public research university. The contract supports "Computational Thinking to Support Clinicians and Biomedical Scientists" and was funded through the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation. As a prime contractor, the University of Pittsburgh will provide research and...

The University of Pittsburgh was awarded a $3,160,781 firm fixed-price contract by the Centers for Disease Control and Prevention (CDC) to develop an Overdose Modeling Tool. This contract, which runs through September 2025, does not have a set-aside designation. The University of Pittsburgh, a state-related research university, frequently partners with government agencies on federally funded research and development projects across various scientific and medical disciplines. Additionally, the university holds an Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID) to provide preclinical models of infectious diseases, which enables NIAID to rapidly initiate new studies in support of its mission to research, treat, and prevent infectious diseases.

Generated 3/13/25, 10:12 AM